Anthem Inc (NYSE:ANTM) EVP Peter D. Haytaian sold 3,500 shares of the company’s stock in a transaction dated Friday, October 26th. The stock was sold at an average price of $267.59, for a total transaction of $936,565.00. Following the transaction, the executive vice president now owns 48,206 shares of the company’s stock, valued at approximately $12,899,443.54. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
ANTM stock opened at $265.93 on Friday. The stock has a market capitalization of $69.02 billion, a price-to-earnings ratio of 22.09, a price-to-earnings-growth ratio of 1.45 and a beta of 0.92. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.52 and a quick ratio of 1.52. Anthem Inc has a 12 month low of $208.40 and a 12 month high of $283.06.
Anthem (NYSE:ANTM) last released its quarterly earnings data on Wednesday, October 31st. The company reported $3.81 EPS for the quarter, beating the Zacks’ consensus estimate of $3.70 by $0.11. Anthem had a net margin of 4.79% and a return on equity of 13.28%. The company had revenue of $22.98 billion during the quarter, compared to the consensus estimate of $22.85 billion. During the same quarter in the prior year, the firm earned $2.65 EPS. Anthem’s quarterly revenue was up 4.0% on a year-over-year basis. On average, sell-side analysts expect that Anthem Inc will post 15.48 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, December 21st. Stockholders of record on Wednesday, December 5th will be paid a $0.75 dividend. The ex-dividend date of this dividend is Tuesday, December 4th. This represents a $3.00 annualized dividend and a dividend yield of 1.13%. Anthem’s dividend payout ratio (DPR) is 24.92%.
A number of research firms have commented on ANTM. BMO Capital Markets upgraded shares of Anthem from a “market perform” rating to an “outperform” rating and increased their price objective for the company from $275.00 to $290.00 in a report on Monday, July 9th. Cantor Fitzgerald reiterated a “buy” rating and issued a $275.00 price objective on shares of Anthem in a report on Wednesday, July 25th. Morgan Stanley increased their price objective on shares of Anthem from $269.00 to $273.00 and gave the company an “equal weight” rating in a report on Thursday, July 26th. Jefferies Financial Group reiterated a “buy” rating and issued a $296.00 price objective on shares of Anthem in a report on Thursday, July 26th. Finally, Credit Suisse Group increased their price objective on shares of Anthem from $284.00 to $311.00 and gave the company an “outperform” rating in a report on Tuesday, September 4th. Four research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Anthem currently has an average rating of “Buy” and an average price target of $284.06.
Institutional investors have recently bought and sold shares of the company. Livingston Group Asset Management CO operating as Southport Capital Management purchased a new stake in shares of Anthem in the 3rd quarter valued at approximately $108,000. Legacy Advisors LLC purchased a new position in shares of Anthem during the 3rd quarter worth approximately $113,000. JNBA Financial Advisors purchased a new position in shares of Anthem during the 3rd quarter worth approximately $134,000. Flagship Harbor Advisors LLC purchased a new position in shares of Anthem during the 2nd quarter worth approximately $120,000. Finally, Patriot Financial Group Insurance Agency LLC purchased a new position in shares of Anthem during the 3rd quarter worth approximately $140,000. 86.85% of the stock is owned by institutional investors and hedge funds.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Featured Story: NASDAQ
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.